AAAAAA

   
Results: 1-9 |
Results: 9
Low molecular weight heparin prevents activation of coagulation in a hypobaric environment
Authors: Bendz, B Sevre, K Andersen, TO Sandset, PM
Citation: B. Bendz et al., Low molecular weight heparin prevents activation of coagulation in a hypobaric environment, BL COAG FIB, 12(5), 2001, pp. 371-374
The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - Results from a randomized, double-blind, clinical trial
Authors: Hoibraaten, E Qvigstad, E Andersen, TO Mowinckel, MC Sandset, PM
Citation: E. Hoibraaten et al., The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - Results from a randomized, double-blind, clinical trial, THROMB HAEM, 85(5), 2001, pp. 775-781
The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties
Authors: Bergholtz, S Andersen, TO Andersson, KB Borrebaek, J Luscher, B Gabrielsen, OS
Citation: S. Bergholtz et al., The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties, NUCL ACID R, 29(17), 2001, pp. 3546-3556
Hypobaric hypoxia - Reply
Authors: Bendz, B Rostrup, M Sevre, K Andersen, TO Sandset, PM
Citation: B. Bendz et al., Hypobaric hypoxia - Reply, LANCET, 357(9260), 2001, pp. 955-956
Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins
Authors: Bendz, B Andersen, TO Sandset, PM
Citation: B. Bendz et al., Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins, BL COAG FIB, 11(4), 2000, pp. 343-348
Association between acute hypobaric hypoxia and activation of coagulation in human beings
Authors: Bendz, B Rostrup, M Sevre, K Andersen, TO Sandset, PM
Citation: B. Bendz et al., Association between acute hypobaric hypoxia and activation of coagulation in human beings, LANCET, 356(9242), 2000, pp. 1657-1658
The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: Results from the estrogen in women with atherosclerosis study
Authors: Hoibraaten, E Os, I Seljeflot, I Andersen, TO Hofstad, AE Sandset, PM
Citation: E. Hoibraaten et al., The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: Results from the estrogen in women with atherosclerosis study, THROMB RES, 98(1), 2000, pp. 19-27
A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1
Authors: Bendz, B Andersen, TO Sandset, PM
Citation: B. Bendz et al., A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1, THROMB RES, 97(6), 2000, pp. 463-472
Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins
Authors: Bendz, B Hansen, JB Andersen, TO Ostergaard, P Sandset, PM
Citation: B. Bendz et al., Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins, BR J HAEM, 107(4), 1999, pp. 756-762
Risultati: 1-9 |